MedPath

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

Phase 4
Terminated
Conditions
Meniere's Disease
Interventions
Registration Number
NCT02530931
Lead Sponsor
University Hospital, Grenoble
Brief Summary

* This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in patient's with Meniere's disease.

* MR Perfusion Imaging will be assess in both cochlea as well

* Primary auditory brain pathways will be evaluated through MR diffusion imaging

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
  • Informed consent signed
  • Medical examination performed prior to participation in research
  • Patients with clinical criteria of Meniere's disease according to the classification of the American Association of Otology (ie the combination of a sensorineural hearing loss at low frequencies, recurrent vertigo and tinnitus and / or clogged ear sensation)
  • Recipient of a French social security scheme
Exclusion Criteria
  • Patients minors
  • Patients on a legal protection regime type guardianship
  • Respiratory pathologies, cardiovascular, renal, diabetes
  • Claustrophobia
  • Contraindications to exposure to a magnetic field
  • Contraindications to injecting Dotarem ®

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
patients with Meniere's diseaseGadolinium-
Primary Outcome Measures
NameTimeMethod
Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted-Imaging dynamic measurementOne MR scan (4 hours)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

GrenobleUniversityHospital

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath